The Aerobiology and Animal Models Core will provide animal models using BSL3 NIH priority pathogens to respond to the scientific needs of SERCEB investigators. The Core will be located in the NIAID-funded Regional Biocontainment Laboratory (RBL) at Duke. The Core will develop and characterize specific models based on SERCEB research priorities, and will use the models to test specific hypotheses developed by SERCEB investigators. Core services will include local animal approval, animal acquisition, growth and characterization of inoculum, delivery and confirmation of challenge dose, animal monitoring, serum and tissue collection, determination of colony-forming units or plaque-forming units, and data analysis. The Core will provide wellcharacterized challenges by the aerosol route, either whole body or nose-only, and by other routes as appropriate to scientific hypotheses. The Core will register and acquire Select Agents in the RBL, and will maintain real-time inventory of these agents in storage, in use, and in animals. The Core will coordinate with the SERCEB BSL3 Host- Pathogen Interaction Flow and Imaging Core located in the RBL to provide live BSL3 cell sorting and analysis, BSL3 whole-body imaging using the MS system with both luminescence and fluorescence capabilities, multiplex cytokine determination, and other immunological studies. Murine models using Yersinia pestis, Bacillus anthracis, and Mycobacterium tuberculosis are in place or will be in place in the RBL at the beginning of the grant period. Other models will be developed over the course of the grant period using other agents and other mammalian species, based on the research needs of SERCEB investigators. The Core will be available to provide surge capacity to local, state, and federal officials in the event of a public health emergency

Public Health Relevance

The ultimate goals for the core are to support basic research leading to better drugs, diagnostics and vaccines against emerging infections and biological threat agents. The Core will provide challenge models to dentists throughout the region who are not able to handle hazardous microbial agents in animals, or who need specialized core services available in the facility.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Specialized Center--Cooperative Agreements (U54)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1-DDS-M)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of North Carolina Chapel Hill
Chapel Hill
United States
Zip Code
Guo, Haitao; Gao, Jianmei; Taxman, Debra J et al. (2014) HIV-1 infection induces interleukin-1? production via TLR8 protein-dependent and NLRP3 inflammasome mechanisms in human monocytes. J Biol Chem 289:21716-26
Emery, Felicia D; Stabenow, Jennifer M; Miller, Mark A (2014) Efficient inactivation of Burkholderia pseudomallei or Francisella tularensis in infected cells for safe removal from biosafety level 3 containment laboratories. Pathog Dis 71:276-81
Rice, Amanda D; Adams, Mathew M; Lindsey, Scott F et al. (2014) Protective properties of vaccinia virus-based vaccines: skin scarification promotes a nonspecific immune response that protects against orthopoxvirus disease. J Virol 88:7753-63
Pop, Laurentiu M; Barman, Stephen; Shao, Chunli et al. (2014) A reevaluation of CD22 expression in human lung cancer. Cancer Res 74:263-71
Agnihothram, Sudhakar; Yount Jr, Boyd L; Donaldson, Eric F et al. (2014) A mouse model for Betacoronavirus subgroup 2c using a bat coronavirus strain HKU5 variant. MBio 5:e00047-14
Zellweger, Raphaƫl M; Eddy, William E; Tang, William W et al. (2014) CD8+ T cells prevent antigen-induced antibody-dependent enhancement of dengue disease in mice. J Immunol 193:4117-24
Zhao, Jincun; Li, Kun; Wohlford-Lenane, Christine et al. (2014) Rapid generation of a mouse model for Middle East respiratory syndrome. Proc Natl Acad Sci U S A 111:4970-5
Krumm, Stefanie A; Yan, Dan; Hovingh, Elise S et al. (2014) An orally available, small-molecule polymerase inhibitor shows efficacy against a lethal morbillivirus infection in a large animal model. Sci Transl Med 6:232ra52
Blake, Lauren E; Garcia-Blanco, Mariano A (2014) Human genetic variation and yellow fever mortality during 19th century U.S. epidemics. MBio 5:e01253-14
de Alwis, Ruklanthi; de Silva, Aravinda M (2014) Measuring antibody neutralization of dengue virus (DENV) using a flow cytometry-based technique. Methods Mol Biol 1138:27-39

Showing the most recent 10 out of 288 publications